Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (241-250 of 467) with videos related to

Pageof 47
Sort By:
The New Microbiologica|October 27, 2025
HIV and Sexual Health Awareness Among University Students: Findings from a World AIDS Day Survey in MilanAngelo Roberto Raccagni, Camilla Abello, Vincenzo Stabile, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013Antonella d'Arminio Monforte, Laura Galli, Sergio Lo Caputo, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2008
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patientsDaniel Gonzalez de Requena, Stefano Bonora, Antonella Castagna, et al.
The New Microbiologica|October 6, 2016
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR StudySilvia Nozza, Angela Rosa Pignataro, Laura Galli, et al.
AIDS (London, England)|July 25, 2014
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety resultsAntonella Castagna, Vincenzo Spagnuolo, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2017
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIVAndrea De Luca, Patrizia Lorenzini, Antonella Castagna, et al.
Journal of Global Antimicrobial Resistance|November 19, 2022
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failuresRoberta Gagliardini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Microorganisms|January 8, 2025
High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening ApproachesElena Bruzzesi, Federica Gandini, Sara Diotallevi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2024
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Domenico Pontillo, Tommaso Clemente, et al.
AIDS (London, England)|February 26, 2025
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimensMichele Bellomo, Nicola Gianotti, Hamid Hasson, et al.
Pageof 47

Showing results (241-250 of 467) with videos related to

Sort By:
Pageof 47
The New Microbiologica|October 27, 2025
HIV and Sexual Health Awareness Among University Students: Findings from a World AIDS Day Survey in MilanAngelo Roberto Raccagni, Camilla Abello, Vincenzo Stabile, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2014
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013Antonella d'Arminio Monforte, Laura Galli, Sergio Lo Caputo, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2008
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patientsDaniel Gonzalez de Requena, Stefano Bonora, Antonella Castagna, et al.
The New Microbiologica|October 6, 2016
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR StudySilvia Nozza, Angela Rosa Pignataro, Laura Galli, et al.
AIDS (London, England)|July 25, 2014
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety resultsAntonella Castagna, Vincenzo Spagnuolo, Laura Galli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2017
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIVAndrea De Luca, Patrizia Lorenzini, Antonella Castagna, et al.
Journal of Global Antimicrobial Resistance|November 19, 2022
Real world efficacy of dolutegravir plus lamivudine in people living with HIV with undetectable viral load after previous failuresRoberta Gagliardini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.
Microorganisms|January 8, 2025
High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening ApproachesElena Bruzzesi, Federica Gandini, Sara Diotallevi, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2024
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Domenico Pontillo, Tommaso Clemente, et al.
AIDS (London, England)|February 26, 2025
Doravirine associated with greater LDL cholesterol reduction in people with HIV switching antiretroviral regimensMichele Bellomo, Nicola Gianotti, Hamid Hasson, et al.
Pageof 47